Select Publications

Journal articles

Schwartz OS; Amminger P; Baune BT; Bedi G; Berk M; Cotton SM; Daglas-Georgiou R; Glozier N; Harrison B; Hermens DF; Jennings E; Lagopoulos J; Loo C; Mallawaarachchi S; Martin D; Phelan B; Read N; Rodgers A; Schmaal L; Somogyi AA; Thurston L; Weller A; Davey CG, 2023, 'The Study of Ketamine for Youth Depression (SKY-D): study protocol for a randomised controlled trial of low-dose ketamine for young people with major depressive disorder', Trials, 24,

Lee W; Sheehan C; Chye R; Chang S; Bayes A; Loo C; Draper B; Agar MR; Currow DC, 2023, 'Subcutaneous ketamine infusion in palliative patients for major depressive disorder (SKIPMDD)—Phase II single-arm open-label feasibility study', PLoS ONE, 18,

Koh AHK; Tan XW; Tor PC; Chatterton ML; Martin DM; Loo CK, 2023, 'The association between outpatient continuation/maintenance electroconvulsive therapy, readmission risk and total direct cost in patients with depressive, bipolar and psychotic disorders: A naturalistic retrospective cohort study', Journal of Affective Disorders, 338, pp. 289 - 298,

Sarma S; Branjerdporn G; Mccosker L; Dong V; Martin D; Loo C, 2023, 'Impact on Electroconvulsive Therapy Services, Including Patient Relapse and Death, During the COVID-19 Pandemic: Quantitative Results From a Multinational Survey', Journal of ECT, 39, pp. 179 - 184,

Gill S; Hussain S; Purushothaman S; Sarma S; Weiss A; Chamoli S; Fasnacht M; Gandhi A; Fitzgerald PB; Simpson B; Loo CK, 2023, 'Prescribing electroconvulsive therapy for depression: Not as simple as it used to be', Australian and New Zealand Journal of Psychiatry, 57, pp. 1202 - 1207,

Purushothaman S; Simpson B; Hussain S; Loo CK; Gill S; Chamoli S; Weiss A; Sarma S; Fitzgerald PB; Fasnacht M; Gandhi A, 2023, 'Electroconvulsive therapy Credentialing for Psychiatrists-Review of Required Standards Across States and Territories in Australia.', J ECT,

Nikolin S; Rodgers A; Schwaab A; Bahji A; Zarate C; Vazquez G; Loo C, 2023, 'Ketamine for the treatment of major depression: a systematic review and meta-analysis', eClinicalMedicine, 62,

Nikolin S; Moffa A; Razza L; Martin D; Brunoni A; Palm U; Padberg F; Bennabi D; Haffen E; Blumberger DM; Salehinejad MA; Loo CK, 2023, 'Time-course of the tDCS antidepressant effect: An individual participant data meta-analysis', Progress in Neuro-Psychopharmacology and Biological Psychiatry, 125,

Thornton NLR; Kawalsky J; Milton A; Klinner C; Schokman A; Stratton E; Loo CK; Glozier N, 2023, 'A systematic review of the print media representation of ketamine treatments for psychiatric disorders', BJPsych Open, 9,

Nikolin S; Martin D; Loo CK; Boonstra TW, 2023, 'Transcranial Direct Current Stimulation Modulates Working Memory Maintenance Processes in Healthy Individuals', Journal of Cognitive Neuroscience, 35, pp. 468 - 484,

Martin DM; Rushby JA; De Blasio FM; Wearne T; Osborne-Crowley K; Francis H; Xu M; Loo C; McDonald S, 2023, 'The effect of tDCS electrode montage on attention and working memory', Neuropsychologia, 179, pp. 108462 - 108462,

Harvey AJ; Nikolin S; Chand N; Flanney W; Tan L; Moffa A; Loo CK; Martin DM, 2023, 'Change in Negative Affective Bias following a Single Ketamine Treatment for Treatment-Resistant Depression', Depression and Anxiety, 2023, pp. 1 - 8,

Xu M; Nikolin S; Samaratunga N; Chow EJH; Loo CK; Martin DM, 2023, 'Cognitive Effects Following Offline High-Frequency Repetitive Transcranial Magnetic Stimulation (HF-rTMS) in Healthy Populations: A Systematic Review and Meta-Analysis', Neuropsychology Review,

Loo C; Glozier N; Barton D; Baune BT; Mills NT; Fitzgerald P; Glue P; Sarma S; Galvez-Ortiz V; Hadzi-Pavlovic D; Alonzo A; Dong V; Martin D; Nikolin S; Mitchell PB; Berk M; Carter G; Hackett M; Leyden J; Hood S; Somogyi AA; Lapidus K; Stratton E; Gainsford K; Garg D; Thornton NLR; Fourrier C; Richardson K; Rozakis D; Scaria A; Mihalopoulos C; Chatterton ML; McDonald WM; Boyce P; Holtzheimer PE; Kozel FA; Riva-Posse P; Rodgers A, 2023, 'Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial', British Journal of Psychiatry,

Rodgers A; Bahceci D; Davey CG; Chatterton ML; Glozier N; Hopwood M; Loo C, 2023, 'Ensuring the affordable becomes accessible–lessons from ketamine, a new treatment for severe depression', Australian and New Zealand Journal of Psychiatry,

Aoki N; Suwa T; Takekita Y; Kawashima H; Kinoshita T; Loo C; Wada K; Takebayashi M, 2023, 'A Nationwide Survey of Continuous and Maintenance ECT in Japan', Brain Stimulation, 16, pp. 349 - 349,

Aoki N; Takekita Y; Kawashima H; Suwa T; Yasuda K; Niina U; Kinoshita T; Loo C, 2023, 'Approach to Establish a Foundation for Japan National Registry Research in ECT', Brain Stimulation, 16, pp. 349 - 349,

Xu M; Nikolin S; Samaratunga N; Hui Chow EJ; Loo CK; Martin D, 2023, 'Cognitive enhancement following offline high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) in healthy populations: A systematic review and meta-analysis', Brain Stimulation, 16, pp. 258 - 258,

Aoki N; Takekita Y; Suwa T; Kawashima H; Okugawa G; Shimizu T; Nishimoto D; Kinoshita T; Loo C, 2023, 'Effects of Anesthesia-ECT Time Interval on Seizure Quality and Clinical Outcome: An Interim Report on a Prospective Randomized Trial of AETI 150 sec vs. 240 sec', Brain Stimulation, 16, pp. 348 - 348,

Sarma S; Branjerdporn G; McCosker L; Dong V; Martin D; Loo C, 2023, 'Impacts on electroconvulsive therapy (ECT) services, including patient relapse and death, during the COVID-19 pandemic: Mixed methods results from a multi-national survey', Brain Stimulation, 16, pp. 7 - 7,

Nikolin S; Owens K; Francis-Taylor R; Chaimani A; Martin DM; Bull M; Sackeim HA; McLoughlin DM; Sienaert P; Kellner CH; Loo C, 2022, 'Comparative efficacy, cognitive effects and acceptability of electroconvulsive therapies for the treatment of depression: Protocol for a systematic review and network meta-analysis', BMJ Open, 12,

Moffa AH; Boonstra TW; Wang A; Martin D; Loo C; Nikolin S, 2022, 'Neuromodulatory effects of theta burst stimulation to the prefrontal cortex', Scientific Data, 9,

Rimmer RM; Costafreda SG; Mutz J; Joseph K; Brunoni AR; Loo CK; Padberg F; Palm U; Fu CHY, 2022, 'Transcranial direct current stimulation effects in late life depression: A meta-analysis of individual participant data', Journal of Affective Disorders Reports, 10, pp. 100407 - 100407,

Sarma S; Branjerdporn G; McCosker L; Kenworthy S; Ryan L; Dong V; Martin D; O’Shea H; Loo C, 2022, 'Strategies from A Multi-National Sample of Electroconvulsive Therapy (ECT) Services: Managing Anesthesia for ECT during the COVID-19 Pandemic', Psychiatry International, 3, pp. 320 - 331,

Brunoni AR; Ekhtiari H; Antal A; Auvichayapat P; Baeken C; Benseñor IM; Bikson M; Boggio P; Borroni B; Brighina F; Brunelin J; Carvalho S; Caumo W; Ciechanski P; Charvet L; Clark VP; Cohen Kadosh R; Cotelli M; Datta A; Deng ZD; De Raedt R; De Ridder D; Fitzgerald PB; Floel A; Frohlich F; George MS; Ghobadi-Azbari P; Goerigk S; Hamilton RH; Jaberzadeh SJ; Hoy K; Kidgell DJ; Zonoozi AK; Kirton A; Laureys S; Lavidor M; Lee K; Leite J; Lisanby SH; Loo C; Martin DM; Miniussi C; Mondino M; Monte-Silva K; Morales-Quezada L; Nitsche MA; Okano AH; Oliveira CS; Onarheim B; Pacheco-Barrios K; Padberg F; Nakamura-Palacios EM; Palm U; Paulus W; Plewnia C; Priori A; Rajji TK; Razza LB; Rehn EM; Ruffini G; Schellhorn K; Zare-Bidoky M; Simis M; Skorupinski P; Suen P; Thibaut A; Valiengo LCL; Vanderhasselt MA; Vanneste S; Venkatasubramanian G; Violante IR; Wexler A; Woods AJ; Fregni F, 2022, 'Digitalized transcranial electrical stimulation: A consensus statement', Clinical Neurophysiology, 143, pp. 154 - 165,

Waite S; Tor PC; Mohan T; Davidson D; Hussain S; Dong V; Loo CK; Martin DM, 2022, 'The utility of the Sydney Melancholia Prototype Index (SMPI) for predicting response to electroconvulsive therapy in depression: A CARE Network study', Journal of Psychiatric Research, 155, pp. 180 - 185,

Branjerdporn G; Sarma S; McCosker L; Dong V; Martin D; Loo C, 2022, '“ECT should never stop”: Exploring the experiences and recommendations of ECT clinical directors and anesthetists about ECT during the COVID-19 pandemic', Frontiers in Psychiatry, 13, pp. 946748,

Abuhelwa AY; Somogyi AA; Loo CK; Glue P; Barratt DT; Foster DJR, 2022, 'Population Pharmacokinetics and Pharmacodynamics of the Therapeutic and Adverse Effects of Ketamine in Patients With Treatment-Refractory Depression', Clinical Pharmacology and Therapeutics, 112, pp. 720 - 729,

Moffa AH; Nikolin S; Martin D; Loo C; Boonstra TW, 2022, 'Reliability of transcranial magnetic stimulation evoked potentials to detect the effects of theta-burst stimulation of the prefrontal cortex', Neuroimage: Reports, 2,

Bayes AJ; Loo CK, 2022, 'Esketamine A nasal spray for treatment-resistant depression', Medicine Today, 23, pp. 68 - 70

Fitzgerald PB; Gill S; Breakspear M; Kulkarni J; Chen L; Pridmore S; Purushothaman S; Galletly C; Clarke P; Ng F; Hussain S; Chamoli S; Csizmadia T; Tolan P; Cocchi L; Ibrahim OAM S; Shankar K; Sarma S; Lau M; Loo C; Yadav T; Hoy KE, 2022, 'Revisiting the effectiveness of repetitive transcranial magnetic stimulation treatment in depression, again', Australian and New Zealand Journal of Psychiatry, 56, pp. 905 - 909,

Martin DM; Loo CK, 2022, 'Further Evidence Supporting the Utility of ECT for People With Cognitive Impairment', American Journal of Geriatric Psychiatry, 30, pp. 799 - 800,

Bayes A; Short B; Zarate CA; Park L; Murrough JW; McLoughlin DM; Riva-Posse P; Schoevers R; Veraart J; Parikh S; Glue P; Fam J; McShane R; Galvez V; Martin D; Tor PC; Brunoni A; Loo CK, 2022, 'The Ketamine Side Effect Tool (KSET): A comprehensive measurement-based safety tool for ketamine treatment in psychiatry', Journal of Affective Disorders, 308, pp. 44 - 46,

Le B; Alonzo A; Bull M; Kabourakis M; Martin D; Loo C, 2022, 'A Clinical Case Series of Acute and Maintenance Home Administered Transcranial Direct Current Stimulation in Treatment-Resistant Depression', The journal of ECT, 38, pp. e11 - e19,

Hendriks L; Mihalopoulos C; Le LKD; Loo C; Chatterton ML, 2022, 'Cost-utility analysis of repetitive transcranial magnetic stimulation as add-on therapy to standard care for the treatment of hallucinations in schizophrenia', European Psychiatry, 65,

Nikolin S; Chand N; Martin D; Rushby J; Loo CK; Boonstra TW, 2022, 'Little evidence for a reduced late positive potential to unpleasant stimuli in major depressive disorder', Neuroimage: Reports, 2, pp. 100077 - 100077,

Kwan E; Le B; Loo CK; Dong V; Tor PC; Davidson D; Mohan T; Waite S; Branjerdporn G; Sarma S; Hussain S; Martin DM, 2022, 'The Impact of COVID-19 on Electroconvulsive Therapy: A Multisite, Retrospective Study from the Clinical Alliance and Research in Electroconvulsive Therapy and Related Treatments Network', Journal of ECT, 38, pp. 45 - 51,

Wang A; Nikolin S; Moffa AH; Loo CK; Martin DM, 2022, 'A novel approach for targeting the left dorsolateral prefrontal cortex for transcranial magnetic stimulation using a cognitive task', Experimental Brain Research, 240, pp. 71 - 80,

Antal A; Luber B; Brem AK; Bikson M; Brunoni AR; Cohen Kadosh R; Dubljević V; Fecteau S; Ferreri F; Flöel A; Hallett M; Hamilton RH; Herrmann CS; Lavidor M; Loo C; Lustenberger C; Machado S; Miniussi C; Moliadze V; Nitsche MA; Rossi S; Rossini PM; Santarnecchi E; Seeck M; Thut G; Turi Z; Ugawa Y; Venkatasubramanian G; Wenderoth N; Wexler A; Ziemann U; Paulus W, 2022, 'Non-invasive brain stimulation and neuroenhancement', Clinical Neurophysiology Practice, 7, pp. 146 - 165,

Martin DM; Tor PC; Waite S; Mohan T; Davidson D; Sarma S; Branjerdporn G; Dong V; Kwan E; Loo CK, 2022, 'The utility of the brief ECT cognitive screen (BECS) for early prediction of cognitive adverse effects from ECT: A CARE network study', Journal of Psychiatric Research, 145, pp. 250 - 255,

Nikolin S; Chand N; Martin D; Rushby J; Loo CK; Boonstra TW, 2022, 'Lack of Evidence for a Reduced Late Positive Potential in Major Depressive Disorder', N

Nikolin S; Tan YY; Martin D; Moffa A; Loo CK; Boonstra TW, 2021, 'Behavioural and neurophysiological differences in working memory function of depressed patients and healthy controls', Journal of Affective Disorders, 295, pp. 559 - 568,

Ferraro MC; Bagg MK; Wewege MA; Cashin AG; Leake HB; Rizzo RRN; Jones MD; Gustin SM; Day R; Loo CK; McAuley JH, 2021, 'Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis', Systematic Reviews, 10,

Bayes A; Dong V; Martin D; Alonzo A; Kabourakis M; Loo C, 2021, 'Ketamine treatment for depression: A model of care', Australian and New Zealand Journal of Psychiatry, 55, pp. 1134 - 1143,

Perkins D; Sarris J; Rossell S; Bonomo Y; Forbes D; Davey C; Hoyer D; Loo C; Murray G; Hood S; Schubert V; Galvão-Coelho NL; O’Donnell M; Carter O; Liknaitzky P; Williams M; Siskind D; Penington D; Berk M; Castle D, 2021, 'Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm', Australian and New Zealand Journal of Psychiatry, 55, pp. 1127 - 1133,

Martin DM; Bakir AA; Lin F; Francis-Taylor R; Alduraywish A; Bai S; Hadzi-Pavlovic D; Dokos S; Loo CK, 2021, 'Effects of modifying the electrode placement and pulse width on cognitive side effects with unilateral ECT: A pilot randomised controlled study with computational modelling', Brain Stimulation, 14, pp. 1489 - 1497,

Tor PC; Tan XW; Martin D; Loo C, 2021, 'Comparative outcomes in electroconvulsive therapy (ECT): A naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia', European Neuropsychopharmacology, 51, pp. 43 - 54,

McAllister-Williams RH; Aaronson ST; Conway CR; Demyttenaere K; Fitzgerald PB; Loo CK; Mitchell PB; Rush AJ; Sackeim HA; Young AH, 2021, 'The ‘difficult-to-treat depression’ and the ‘response paradigm’ models: Implications and relevance to patient management', Australian and New Zealand Journal of Psychiatry, 55, pp. 824 - 825,

Anderson IM; Hamish McAllister-Williams R; Downey D; Elliott R; Loo C, 2021, 'Cognitive function after electroconvulsive therapy for depression: Relationship to clinical response', Psychological Medicine, 51, pp. 1647 - 1656,

Lee W; Sheehan C; Chye R; Chang S; Loo C; Draper B; Agar M; Currow DC, 2021, 'Study protocol for SKIPMDD: Subcutaneous ketamine infusion in palliative care patients with advanced life limiting illnesses for major depressive disorder (phase II pilot feasibility study)', BMJ Open, 11,

Back to profile page